HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperbaric oxygenation combined with nifedipine treatment for recent-onset retinal artery occlusion.

Abstract
We describe the results of early hyperbaric oxygenation combined with nifedipine treatment for central retinal artery occlusion, and explain the results pathophysiologically. We report four cases in which hyperbaric oxygenation therapy was applied in combination with nifedipine, eyeball massage, and glycerol for the treatment of central retinal artery occlusion. In two of the cases in which therapy was started less than 100 minutes after the acute onset of visual loss and one case in which therapy was started during the course of central arterial occlusion, considerable improvement in visual acuity was observed, while in the fourth case in which therapy was started six hours after the acute onset of visual loss, no improvement appeared. We conclude from these results that hyperbaric oxygenation therapy has a beneficial effect on the final visual outcome of central retinal artery occlusion, provided it is applied early enough. Further investigation is needed to fully define the nature and terms of this beneficial effect.
AuthorsI Beiran, P Reissman, J Scharf, Z Nahum, B Miller
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) 1993 Apr-Jun Vol. 3 Issue 2 Pg. 89-94 ISSN: 1120-6721 [Print] United States
PMID8353436 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Nifedipine
  • Glycerol
Topics
  • Adult
  • Aged
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Glycerol (administration & dosage)
  • Humans
  • Hyperbaric Oxygenation
  • Male
  • Massage
  • Middle Aged
  • Nifedipine (therapeutic use)
  • Retinal Artery Occlusion (therapy)
  • Time Factors
  • Visual Acuity
  • Visual Fields

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: